Last update :
19/11/2024
Thrombolytic   Urokinase  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Abbokinase Austria, Chile, Spain, Sweden, United States of America
Actosolv Belgium, France, Italy, Luxembourg
Alfakinasi Italy
Angikinase Egypt
Corase Germany
Dabunase India
Dukinase India
KD Unase India
Kisolv Italy
Lynlitic Canada
Medacinase Netherlands
Persolv Italy
Rheotromb Germany
Syner-Kinase Great Britain
Ukidan Greece
Urochinasi Italy
Urokinasa Poland
Urokinase Austria, Germany, Luxembourg, Malaysia, Netherlands, New Zealand, Spain, Switzerland
Uroquidan Spain
Uroquinasa Chile
Stability in solutions   injection   Stability in solutions : Urokinase     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass NaCl 0,9% or Glucose 5% 0,005 MUI/ml 22-25°C Light
24 Hour
375
Biological analysis

Polypropylen Syringe Water for Injection 0,0025 > 0,025 MUI/ml -30°C Protect from light
30 Day
1941

Polypropylen Syringe Water for Injection 0,005 MUI/ml -20°C Protect from light
182 Day
1061

Polypropylen Syringe NaCl 0,9% or Glucose 5% 0,005 MUI/ml 22-25°C Light
24 Hour
375
Biological analysis

Polypropylen Syringe Sodium chloride 0,9% 0,005 MUI/ml -20°C Not specified
56 Day
2050
Biological analysis

Polypropylen Syringe Sodium chloride 0,9% 0,005 MUI/ml 37°C Not specified
56 Day
2050
Biological analysis

Polypropylen Syringe Sodium chloride 0,9% 0,005 MUI/ml 7°C Not specified
56 Day
2050
Biological analysis


  Mentions Légales